Bhuvi Eti Raxwal

Bhuvi Eti Raxwal Bhuvi Eti Raxwal Bhuvi Eti Raxwal

Bhuvi Eti Raxwal

Bhuvi Eti Raxwal Bhuvi Eti Raxwal Bhuvi Eti Raxwal
  • About Me
  • Non-Profit
    • What is H20 365?
  • Research Lab
    • Research
  • Patent
  • Book
  • More
    • About Me
    • Non-Profit
      • What is H20 365?
    • Research Lab
      • Research
    • Patent
    • Book

  • About Me
  • Non-Profit
    • What is H20 365?
  • Research Lab
    • Research
  • Patent
  • Book

Research Lab

 Welcome to my research journey of co-founding research lab. Exploring the intricacies of inquiry and problem-solving is my true passion. With a heart deeply invested in the world of science, I find immense joy in delving into the realms of preventive and precision medicine. Since childhood, cardiovascular medicine has captivated my interest, driving me to unravel its mysteries and contribute to its advancements. Join me as I embark on a path of discovery and exploration in the fascinating field of research. Case report PUBLISHED with collaborative use of AI tools. 

Artificial intelligence in health care

Role of Artificial Intelligence in Healthcare

A Comparative Analysis of ChatGPT and BARD Artificial Intelligence Language Models for Providing Recommendations on Queries Related to Preventing Cardiovascular Disease.  Research abstract accepted at international conference SCAI for presentation in Long Beach, CA. (May 2024). 

AI in Preventive Cardiology - SCAI conference May 2024

Endoscopic Retrograde Appendicitis Therapy

  The case report about ERAT an innovative promising alternative to immediate appendectomy for patients with appendicitis. A novel technique of stent placement in appendix performed at the Mayo Clinic.  PUBLISHED. Peer review journal. Cureus. Feb 2024.

Endoscopic Retrograde Appendicitis Therapy. Published Feb 2024.

Computational Model to Enhance Understanding of Left Atrial Appendage Pathophysiology

Research presented at SCAI conference. Atrial fibrillation can lead to changes in the heart's atrial structure, particularly in the left atrium and left atrial appendage (LAA). This study examined whether the size of the LAA orifice could predict the amount of energy (measured in joules) needed to restore normal heart rhythm through electrical cardioversion. The research included 65 patients who had successfully undergone cardioversion from atrial fibrillation to normal sinus rhythm. Patients were categorized into two groups based on LAA orifice size: Group 1 with an orifice size of <16 mm and Group 2 with a dilated orifice size of ≥16 mm. The findings revealed that patients with a dilated LAA orifice required a similar amount of energy for successful cardioversion compared to those with a normal-sized orifice, despite some differences in BMI and the prevalence of sleep apnea between the groups. The study suggests that LAA orifice size may not be a significant predictor of cardioversion energy requirements. into the realms of preventive and precision medicine. Since childhood, cardiovascular medicine has captivated my interest, driving me to unravel its mysteries and contribute to its advancements. Join me as I embark on a path of discovery and exploration in the fascinating field of research. PUBLISHED.

Presented at SCAI Conference - Phoenix 2023.

Predicting Energy Requirements for Cardioversion in Atrial Fibrillation

Presented at the American Heart Association conference and published in Circulation.

Atrial fibrillation (AF) is a common heart condition, especially among older individuals, and restoring normal heart rhythm often involves various treatments such as medications, direct current (DC) cardioversion, and ablation. However, it's unclear whether the velocity at which the left atrial appendage (LAA) empties can predict the amount of energy needed for successful DC cardioversion in AF patients. This study aims to investigate the potential link between LAA emptying velocity and the energy requirements for cardioversion in individuals with AF undergoing DC cardioversion. PUBLISHED. Presented at the American Heart Association Scientific Session. 

Presented at AHA- Philadelphia 2023

Safety of COVID-19 Vaccine

  The central objective of this study was to evaluate the safety profiles of different COVID-19 vaccines in individuals with pre-existing cardiovascular conditions. The findings strongly support the safety of COVID-19 vaccination for this group, given the rarity of serious adverse effects. PUBLISHED. Presented at the American College of Cardiology scientific session conference.  New Orleans. 2023.

COVID-19 Vaccine safety study. Presented at ACC.

Copyright © 2024 Bhuvi Raxwal  - All Rights Reserved.

Powered by ABXB

  • About Me
  • Contact

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept